childhood eczema
Conditions
Interventions
Two groups:Pinetarsol (pine tar bath oil 2.3% w/w), 10-20ml daily, 4 weeks (active arm), 10-15 min. daily versus placebo
Sponsors
Hon KL, sponsored by Direct Grant CUHK
Eligibility
Sex/Gender
All
Age
3 Years to 18 Years
Inclusion criteria
Inclusion criteria: only patients with moderate-to-severe eczema of SCORAD (SCORing Atopic Dermatitis) scores >15 points will be recruited
Exclusion criteria
Exclusion criteria: 1. Subjects (patients and parents) have intercurrent illness for two weeks prior to study; 2. received any systemic antibiotics for at least 4 weeks prior; 3. subject with documented allergies to study product components; 4. subject enrolled in another clinical trial during the study period; 5. subject/parent considered by teh investigator to be likely not compliant to be likely not compliant to the protocol.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| S. aureus status (absent, scantly, moderate, heavy growth) during the study period;Skin hydration (SH) and transepidermal water loss (TEWL);Quality of life;Eczema severity blood markers (eg. ige, eosinophils); | — |
Primary
| Measure | Time frame |
|---|---|
| eczema severity; | — |
Countries
China
Contacts
Public ContactKam Lun HON
The Chinese University of Hong Kong
Outcome results
None listed